Camurati-Engelmann Disease - 23 Studies Found
| Completed |
: Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma : Asthma : 2007-09-27 : Drug: montelukast montelukast 5-mg chewable tablet with matching placebo once daily in the evening at be |
| Active, not recruiting |
: Autologous/Allogeneic TGFbeta-resistant LMP2A-specific CTL, Lymphoma (TGF-beta) :
: 2010-10-19 |
| Completed |
: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma :
: 2007-02-05 :
|
| Terminated |
: Anti-TGF-beta Therapy in Patients With Myelofibrosis :
|
| Recruiting |
: SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer :
: 2015-10-16 :
|
| Completed |
: Fresolimumab In Systemic Sclerosis : Diffuse Systemic Sclerosis : 2011-01-25 : Drug: Fresolimumab intravenous fresolimumab 1mg/kg, first 8 patients; 5 mg/kg following 8 patients |
| Not yet recruiting |
: ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer : Rectal Adenocarcinoma : 2016-01-25 :
|
| Completed |
: Radiation Therapy in Treating Women With Invasive Breast Cancer : Breast Cancer : 2006-03-08 :
|
| Completed |
: Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer :
: 2010-01-27 : Biological: Lucanix Monthly intradermal injections of four irradiated allogeneic TGF-beta2 antisense gen |